4//SEC Filing
Cannon Louis A 4
Accession 0001387131-19-003915
CIK 0001528557other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 7:09 PM ET
Size
8.6 KB
Accession
0001387131-19-003915
Insider Transaction Report
Form 4
Cannon Louis A
Director
Transactions
- Purchase
Common Stock
2019-05-22$2.63/sh+7,500$19,719→ 299,767 total
Holdings
- 7,557,436(indirect: See Footnote)
Common Stock
- 573,798(indirect: See Footnote)
Common Stock
Footnotes (6)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.6266 to $2.63, inclusive. The reporting person undertakes to provide Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes 53,326 shares of common stock related to restricted stock units (RSUs) granted as part of the director's 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to the reporting person's continuous service with the Company through each such vesting date.
- [F3]Includes 27,649 shares of common stock related to RSUs granted as part of the director's 2019 annual equity award. The RSUs provide for vesting in quarterly installments on August 3, 2019, November 3, 2019, February 3, 2020 and May 3, 2020, subject to the reporting person's continuous service with the Company through each such vesting date.
- [F4]175,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A Cannon; the remaining shares are held directly.
- [F5]Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P., and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
- [F6]Consists of securities directly owned by BioStar Ventures III-XF, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III-XF, L.P., and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III-XF, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
Documents
Issuer
Corindus Vascular Robotics, Inc.
CIK 0001528557
Entity typeother
Related Parties
1- filerCIK 0001700257
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 7:09 PM ET
- Size
- 8.6 KB